High expression levels of CD90 to predict edema response to steroid treatment in glioblastoma multiforme (GBM) patients.

e13008 Background: GBM is the most aggressive brain tumour in the adult, with a median overall survival about 15 months. Patients usually present with many symptoms due to edema in addition of symp...